Ortega HG - Search Results

1

Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.

Katial RK, Oppenheimer JJ, Ostrom NK, Mosnaim GS, Yancey SW, Waitkus-Edwards KR, Prillaman BA, Ortega HG. Katial RK, et al. Among authors: ortega hg. Allergy Asthma Proc. 2010 Jan-Feb;31(1):68-75. doi: 10.2500/aap.2010.31.3306. Allergy Asthma Proc. 2010. PMID: 20167147 Clinical Trial.

2

Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma.

Pearlman D, Qaqundah P, Matz J, Yancey SW, Stempel DA, Ortega HG. Pearlman D, et al. Among authors: ortega hg. Pediatr Pulmonol. 2009 May;44(5):429-35. doi: 10.1002/ppul.20962. Pediatr Pulmonol. 2009. PMID: 19382218 Clinical Trial.

3

Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.

Camargo CA Jr, Boulet LP, Sutherland ER, Busse WW, Yancey SW, Emmett AH, Ortega HG, Ferro TJ. Camargo CA Jr, et al. Among authors: ortega hg. J Asthma. 2010 Feb;47(1):76-82. doi: 10.3109/02770900903338494. J Asthma. 2010. PMID: 20100025

4

Comparative effect of body mass index on response to asthma controller therapy.

Sutherland ER, Camargo CA Jr, Busse WW, Meltzer EO, Ortega HG, Yancey SW, Emmett AH, Stempel DA. Sutherland ER, et al. Among authors: ortega hg. Allergy Asthma Proc. 2010 Jan-Feb;31(1):20-5. doi: 10.2500/aap.2010.31.3307. Allergy Asthma Proc. 2010. PMID: 20167142 Review.

5

Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.

Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM. Kerwin EM, et al. Among authors: ortega hg. Respir Med. 2008 Apr;102(4):495-504. doi: 10.1016/j.rmed.2007.12.002. Epub 2008 Feb 21. Respir Med. 2008. PMID: 18206361 Free article. Clinical Trial.

6

Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.

Yancey SW, Klotsman M, Ortega HG, Edwards LD, Anderson WH. Yancey SW, et al. Among authors: ortega hg. Curr Med Res Opin. 2009 Apr;25(4):1011-8. doi: 10.1185/03007990902805981. Curr Med Res Opin. 2009. PMID: 19275519

7

Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.

Bleecker ER, Nelson HS, Kraft M, Corren J, Meyers DA, Yancey SW, Anderson WH, Emmett AH, Ortega HG. Bleecker ER, et al. Among authors: ortega hg. Am J Respir Crit Care Med. 2010 Apr 1;181(7):676-87. doi: 10.1164/200809-1511OC. Epub 2009 Nov 12. Am J Respir Crit Care Med. 2010. PMID: 19910613 Clinical Trial.

8

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment.

Magnan A, Bourdin A, Prazma CM, Albers FC, Price RG, Yancey SW, Ortega H. Magnan A, et al. Allergy. 2016 Sep;71(9):1335-44. doi: 10.1111/all.12914. Epub 2016 May 24. Allergy. 2016. PMID: 27087007 Free PMC article.

9

Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events.

Bateman E, Nelson H, Bousquet J, Kral K, Sutton L, Ortega H, Yancey S. Bateman E, et al. Ann Intern Med. 2008 Jul 1;149(1):33-42. doi: 10.7326/0003-4819-149-1-200807010-00229. Epub 2008 Jun 3. Ann Intern Med. 2008. PMID: 18523132 Free article.

10

Retrospective characterization of airway reversibility in patients with asthma responsive to bronchodilators.

Yancey SW, Ortega HG. Yancey SW, et al. Among authors: ortega hg. Curr Med Res Opin. 2007 Dec;23(12):3205-7. doi: 10.1185/030079907X242683. Curr Med Res Opin. 2007. PMID: 18021494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters